Gliclazid-Mepha 30 retard, Depotabs

7680585040030 CH-58504 Tabletten

Associated product:

GLICLAZID Mepha retard depotabs 30 mg 120 pce
Gliclazid-Mepha 30 retard, Depotabs
Gliclazid-Mepha 30 retard, Depotabs
Gliclazid-Mepha 30 retard, Depotabs
1 / 3
google

Article details

Package size
120
Selling units
120
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
14/03/2023
Summary of Product Characteristics
Français
14/03/2023
Summary of Product Characteristics
Italien
14/03/2023
Patient information leaflet
Allemand
16/09/2022
Patient information leaflet
Français
16/09/2022
Patient information leaflet
Italien
16/09/2022

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
73.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 30.30
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/01/2009

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
58504
Drug name
Gliclazid-Mepha 30 retard, Depotabs
Galenic form
TABWF
ATC Code
A10BB09
Authorization status
Z
Dispensing category
B
First authorization
08/07/2008
Authorization expiration date
31/12/9999
IT Number
07.06.2.
Domain
Human medicine
Field of application
orales Antidiabetikum

Package details

Description (FR)
GLICLAZID Mepha retard depotabs 30 mg 120 pce
Description (DE)
GLICLAZID Mepha retard Depotabs 30 mg 120 Stk
Market launch
08/07/2008
Narcotic (BTM)
No

Original drug

Diamicron MR, comprimés à libération modifiée
GTIN: 7680552340064
CHF 18.20
View original

Other package sizes (2)

None
20 TABL
GTIN: None
Not in V1
GLICLAZID Mepha retard depotabs 30 mg 30 pce
30 TABL
GTIN: 7680585040023
View